article thumbnail

FTC and DOJ outline potential changes to agencies’ review of pharmaceutical mergers

JD Supra: Mergers

On June 1, 2023, the Federal Trade Commission (FTC) and the Antitrust Division of the US Department of Justice (DOJ) released a summary of a workshop jointly held by the agencies in June 2022 titled “Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.”

article thumbnail

FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry

JD Supra: Mergers

Department of Justice Antitrust Division, recently released a summary of the Agencies’ June 2022 joint workshop titled “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.” By: Mintz

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The European Commission report on competition enforcement in the pharmaceutical sector

JD Supra: Mergers

On 26 January 2024, the European Commission published a report on competition enforcement in the pharmaceutical sector, highlighting the role of EU competition law in safeguarding market participants and consumers, particularly amid the challenges posed by the Covid-19 crisis.

article thumbnail

The FTC "Settles" For a Conduct Consent Decree to Resolve Its Challenge to the Amgen-Horizon Merger

JD Supra: Mergers

For years, the antitrust enforcement agencies have indicated their antipathy toward resolving competition issues in proposed mergers by entering into consent decrees that prohibit certain conduct, rather than stopping the merger entirely or fixing the competition issues through divestitures. By: Mintz - Antitrust Viewpoints

Mergers 172
article thumbnail

Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.

Global Newswire by Notified: M&A

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

article thumbnail

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Global Newswire by Notified: M&A

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology

Mergers 53
article thumbnail

Amgen-Horizon: The FTC's First Litigated Pharmaceutical Merger Challenge in 14 Years and First Conglomerate Merger Challenge in Decades

JD Supra: Mergers

On May 17, 2023, the Federal Trade Commission (FTC) challenged Amgen Inc.’s s (Amgen) proposed acquisition of Horizon Therapeutics plc (Horizon). The complaint is significant in three respects. By: Wilson Sonsini Goodrich & Rosati

Mergers 130